VYRPX Mutual Fund

VYRPX Mutual Fund

NAV$10.23
See how much of VYRPX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Oct 21, 2026

Net Assets
$16M
Expense Ratio
0.66%
Dividend Yield (Current)
-
Holdings
25
Inception Date
May 2, 2016
Fund Family
Voya Investment Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+2.58%
1 Year+2.96%
3 Year+8.84%
5 Year+2.47%
10 Year+3.67%

Asset Allocation

Stocks: 100.00%
See how much of VYRPX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
2330:TWTaiwan Semiconductor Manufacturing Co Ltd27.93%
GOOGAlphabet Inc Class C26.55%
PLTRPalantir Technologies Inc.9.13%
LRCXLam Research Corp6.22%
KLACKLA Corp4.21%
Top 10 Concentration: 87.39%Report Date: Oct 21, 2026
Download all 25 holdings for VYRPX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$0.54
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

VYRPX Mutual Fund Overview

VYRPX Mutual Fund (Voya Solution Conservative Portfolio Class R6) is managed by Voya Investment Management with $15.8M in net assets. VYRPX expense ratio is 0.66%, holding 25 positions across sectors including Information Technology, Communication Services, Materials. Inception date: 2016-05-02.

VYRPX performance shows a YTD return of 2.58%. The 1-year return is 2.96% and the 5-year return is 2.47%.

VYRPX top holdings include Taiwan Semiconductor Manufacturing Co Ltd (27.9%), Alphabet Inc Class C (26.6%), Palantir Technologies Inc. (9.1%), Lam Research Corp (6.2%), KLA Corp (4.2%). Go to all VYRPX holdings, VYRPX sectors, or VYRPX dividends.

VYRPX can be compared against other funds. Use VYRPX overlap to find shared positions, or VYRPX vs another fund for a side-by-side view. VYRPX alternatives are available via the screener, along with tax-loss harvesting opportunities.